VU 0361737_化学试剂_常用生化试剂_生化试剂库_商城

VU 0361737

产品价格: ￥744.44

最小起订量：暂无可售数量：999盒

发货时限：: 暂无

所在地区：: 中国上海

有效期至：: 长期有效

最后更新：: 2021-04-13 01:30:02

浏览次数：: 18

买家正在看

SPECTROZYME® PCa-活化蛋白C发色底物 ￥1475.00

总胆固醇(TC)检测试剂盒(COD-PAP双试 ￥6.00

1-己基-3-甲基咪唑双（三氟甲磺酰）亚 ￥990.00

货号：	S2892
规格：	10mg/10mM/1mL/50mg

中国库存现货，GluR抑制剂，Selleck Chemicals美国品牌，CAS#1161205-04-4。
更多详情请访问中国唯一官方网站：http://www.selleck.cn/products/vu-0361737.html

生物活性

产品描述	VU 0361737是一种选择性(PAM)mGlu4受体正变构调节剂(PAM)，作用于人类和大鼠受体，EC50分别为240 nM和110 nM，对mGlu5和mGlu8受体具有微弱的作用活性，抑制mGlu1， mGlu2， mGlu3， mGlu6 and mGlu7受体活性，可以渗透进入CNS。
靶点	mGluR4 (Human)	mGluR4 (Rat )
IC50	240 nM	110 nM ^[1]
体外研究	VU0361737 is inactive at mGlu1, mGlu2, mGlu3, mGlu6 and mGlu7 receptors and displays weak activity at mGlu5 and mGlu8 receptors. ^[1]
体内研究	VU0361737 shows high in vivo CL in rat, a short half-life (T_1/2 20 min), and demonstrates significant brain exposure (brain-to-plasma ratio of 4.1). ^[1]
临床实验
特征

推荐的实验操作(此推荐来自于公开的文献所以Selleck并不保证其有效性)

激酶实验: ^[2]

Calcium mobilization assays	Human mGluR4/Gqi5/CHO cells (30,000 cells/20 •l/well) are plated in blackwalled, clear-bottomed, TC treated, 384 well plates in DMEM containing 10% dialyzed FBS, 20 mM HEPES, 100 units/ml penicillin/streptomycin, and 1 mM sodium pyruvate. The cells are grown overnight at 37 °C in the presence of 5% CO₂. During the day of assay, the medium is replaced with 20 μL of 1 μM Fluo-4, AM prepared as a 2.3 mM stock in DMSO and mixed in a 1:1 ratio with 10% (w/v) pluronic acid F-127 and diluted in Assay Buffer (Hank’s balanced salt solution, 20 mM HEPES and 2.5 mM Probenecid) for 45 minutes at 37 °C. Dye is removed and replaced with 20 μL of Assay Buffer. Test compounds are transferred to daughter plates using an Echo acoustic plate reformatter and then diluted into Assay Buffer. Ca²⁺ flux is measured using the Functional Drug Screening System 6000. Baseline readings are taken (10 images at 1 Hz, excitation, 470±20 nm, emission, 540±30 nm) and then 20 •l/well test compounds are added using the FDSS’s integrated pipettor. Cells are incubated with compounds for approximately 2.5 minutes and then an EC20 concentration of glutamate is applied; 2 minutes later an EC80 concentration of glutamate is added. For concentration-response curve experiments, compounds are serially diluted 1:3 into 10 point concentration response curves and are transferred to daughter plates using the Echo. Test compounds are again applied and followed by EC20 concentrations of glutamate. For fold shift experiments, compounds are added at 2X their final concentration and then increasing concentrations of glutamate are added in the presence of vehicle or the appropriate concentration of test compound. Curves are fitted using a four point logistical equation using Microsoft XLfit. Subsequent confirmations of concentrationresponse parameters are performed using independent serial dilutions of source compounds and data from multiple days experiments are integrated and fit using a four point logistical equation in GraphPad Prism. Calcium assays are used to assess activity of compounds at mGluRs 1, 4 and 5.

Calcium mobilization assays

Human mGluR4/Gqi5/CHO cells (30,000 cells/20 •l/well) are plated in blackwalled, clear-bottomed, TC treated, 384 well plates in DMEM containing 10% dialyzed FBS, 20 mM HEPES, 100 units/ml penicillin/streptomycin, and 1 mM sodium pyruvate. The cells are grown overnight at 37 °C in the presence of 5% CO₂. During the day of assay, the medium is replaced with 20 μL of 1 μM Fluo-4, AM prepared as a 2.3 mM stock in DMSO and mixed in a 1:1 ratio with 10% (w/v) pluronic acid F-127 and diluted in Assay Buffer (Hank’s balanced salt solution, 20 mM HEPES and 2.5 mM Probenecid) for 45 minutes at 37 °C. Dye is removed and replaced with 20 μL of Assay Buffer. Test compounds are transferred to daughter plates using an Echo acoustic plate reformatter and then diluted into Assay Buffer. Ca²⁺ flux is measured using the Functional Drug Screening System 6000. Baseline readings are taken (10 images at 1 Hz, excitation, 470±20 nm, emission, 540±30 nm) and then 20 •l/well test compounds are added using the FDSS’s integrated pipettor. Cells are incubated with compounds for approximately 2.5 minutes and then an EC20 concentration of glutamate is applied; 2 minutes later an EC80 concentration of glutamate is added. For concentration-response curve experiments, compounds are serially diluted 1:3 into 10 point concentration response curves and are transferred to daughter plates using the Echo. Test compounds are again applied and followed by EC20 concentrations of glutamate. For fold shift experiments, compounds are added at 2X their final concentration and then increasing concentrations of glutamate are added in the presence of vehicle or the appropriate concentration of test compound. Curves are fitted using a four point logistical equation using Microsoft XLfit. Subsequent confirmations of concentrationresponse parameters are performed using independent serial dilutions of source compounds and data from multiple days experiments are integrated and fit using a four point logistical equation in GraphPad Prism. Calcium assays are used to assess activity of compounds at mGluRs 1, 4 and 5.

动物实验: ^[1]

动物模型	Sprague-Dawley rats
配制	10% Tween-80
剂量	10 mg/kg
给药处理	ip

温馨提示：不可用于临床治疗。

免责声明

本网页所展示的有关【VU 0361737】的信息/图片/参数等由的会员【Selleck中国】提供，由【生物实验采购网】会员【Selleck中国】自行对信息/图片/参数等的真实性、准确性和合法性负责，本平台（本网站）仅提供展示服务，请谨慎交易，因交易而产生的法律关系及法律纠纷由您自行协商解决，本平台（本网站）对此不承担任何责任。您在本网页可以浏览【VU 0361737】有关的信息/图片/价格等及提供【VU 0361737】的商家公司简介、联系方式等信息。

在您的合法权益受到侵害时，请您致电，我们将竭诚为您服务，感谢您对【生物实验采购网】的关注与支持！